Camden National Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Camden National Bank's EW Position: Q3 2024 in Review
Camden National Bank sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 80,191 shares — an estimated $7.41M sold.
Camden National Bank first reported a position in EW in Q2 2020 and held it in 17 quarters. The position peaked at $9.66M in Q4 2021. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.
- Camden National Bank reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
- Camden National Bank sold 80,191 Edwards Lifesciences shares in Q3 2024, an estimated $7.41M.
- Camden National Bank first reported a position in Edwards Lifesciences in Q2 2020 and held it in 17 quarters.
- Camden National Bank's Edwards Lifesciences position peaked at $9.66M in Q4 2021.
- 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.
Based on Camden National Bank's 13F filing for Q3 2024, filed 12 Nov 2024.